| Medical and Health Sciences | Lifetime | 84 | US 47 | 100.00 |
| Medical and Health Sciences | 2021-2025 | 244 | US 87 | 99.95 |
| Medical Genetics | Lifetime | 3 | US 2 | 99.97 |
| Hematology | Lifetime | 11 | US 9 | 99.95 |
| Rheumatology | Lifetime | 57 | US 22 | 99.74 |
| Molecular Biology | Lifetime | 821 | US 486 | 99.57 |
| Immunology | Lifetime | 542 | US 271 | 98.43 |
| Pathology and Forensic Medicine | Lifetime | 781 | US 360 | 96.30 |
| Medical Genetics | 2021-2025 | 5 | US 2 | 99.84 |
| Hematology | 2021-2025 | 14 | US 9 | 99.72 |
| Rheumatology | 2021-2025 | 285 | US 88 | 90.42 |
| Immunology | 2021-2025 | 886 | US 325 | 66.81 |
| Acute Myeloid Leukemia Research | Lifetime | 3 | US 3 | 99.97 |
| Myeloproliferative Neoplasms: Diagnosis and Treatment | Lifetime | 2 | US 2 | 99.96 |
| Chronic Myeloid Leukemia Treatments | Lifetime | 3 | US 3 | 99.95 |
| Kruppel-like factors research | Lifetime | 1 | US 1 | 99.89 |
| Eosinophilic Disorders and Syndromes | Lifetime | 3 | US 3 | 99.96 |
| Hemoglobinopathies and Related Disorders | Lifetime | 6 | US 5 | 99.76 |
| Hematological disorders and diagnostics | Lifetime | 11 | US 8 | 99.68 |
| Mast cells and histamine | Lifetime | 12 | US 6 | 99.65 |
| Chronic Lymphocytic Leukemia Research | Lifetime | 57 | US 35 | 99.76 |
| Platelet Disorders and Treatments | Lifetime | 38 | US 15 | 99.44 |
| Multiple Myeloma Research and Treatments | Lifetime | 48 | US 28 | 99.64 |
| Lymphoma Diagnosis and Treatment | Lifetime | 170 | US 82 | 99.44 |
| Amyloidosis: Diagnosis, Treatment, Outcomes | Lifetime | 93 | US 51 | 98.53 |
| Immunodeficiency and Autoimmune Disorders | Lifetime | 277 | US 130 | 98.64 |
| Blood disorders and treatments | Lifetime | 108 | US 49 | 98.30 |
| Cytokine Signaling Pathways and Interactions | Lifetime | 330 | US 147 | 98.11 |
| Acute Lymphoblastic Leukemia research | Lifetime | 427 | US 216 | 98.39 |
| Bone and Joint Diseases | Lifetime | 315 | US 123 | 97.45 |
| Hematopoietic Stem Cell Transplantation | Lifetime | 748 | US 358 | 97.27 |
| Retinoids in leukemia and cellular processes | Lifetime | 507 | US 263 | 96.08 |
| Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis | Lifetime | 809 | US 339 | 96.42 |
| Renal Diseases and Glomerulopathies | Lifetime | 844 | US 289 | 96.42 |
| Urticaria and Related Conditions | Lifetime | 602 | US 184 | 95.36 |
| Histiocytic Disorders and Treatments | Lifetime | 426 | US 201 | 90.95 |
| Porphyrin Metabolism and Disorders | Lifetime | 879 | US 386 | 90.23 |
| Methemoglobinemia and Tumor Lysis Syndrome | Lifetime | 592 | US 216 | 70.01 |
| Myeloproliferative Neoplasms: Diagnosis and Treatment | 2021-2025 | 3 | US 3 | 99.80 |
| Acute Myeloid Leukemia Research | 2021-2025 | 12 | US 10 | 99.84 |
| Kruppel-like factors research | 2021-2025 | 1 | US 1 | 99.53 |
| Chronic Myeloid Leukemia Treatments | 2021-2025 | 22 | US 15 | 99.53 |
| Eosinophilic Disorders and Syndromes | 2021-2025 | 13 | US 10 | 99.24 |
| Hemoglobinopathies and Related Disorders | 2021-2025 | 66 | US 35 | 97.48 |
| Erythrocyte Function and Pathophysiology | 2021-2025 | 112 | US 46 | 91.69 |
| Chronic Lymphocytic Leukemia Research | 2021-2025 | 722 | US 306 | 93.10 |
| Lymphoma Diagnosis and Treatment | 2021-2025 | 901 | US 364 | 92.63 |
| Blood disorders and treatments | 2021-2025 | 123 | US 33 | 89.79 |
| Mast cells and histamine | 2021-2025 | 140 | US 37 | 90.01 |
| Cytokine Signaling Pathways and Interactions | 2021-2025 | 430 | US 90 | 77.31 |
| Hematological disorders and diagnostics | 2021-2025 | 212 | US 65 | 76.60 |
| Retinoids in leukemia and cellular processes | 2021-2025 | 631 | US 191 | 59.43 |
